Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.40 | N/A | -18.76% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.40 | N/A | -18.76% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of cautious optimism about future growth. They acknowledged current challenges but focused on long-term strategies.
Management emphasized the importance of long-term growth despite short-term challenges.
They highlighted ongoing investments in technology to enhance service delivery.
Teladoc's earnings report shows a miss on EPS, which might raise concerns among investors about profitability. However, the stock rose by 3.34%, indicating that investors may be optimistic about the company's long-term growth strategies. The lack of revenue data and guidance leaves some uncertainty going forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KLA CORP
Jul 30, 2018